Table of Contents
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL Bacteriophage MARKET, BY Product Type
6.1. Overview
6.2. Phage Probiotics
6.3. Phage Therapeutics
7. GLOBAL Bacteriophage MARKET, BY Route of Administration
7.1. Overview
7.2. Oral
7.3. Topical
7.4. Other
8. GLOBAL Bacteriophage MARKET, BY Application
8.1. Overview
8.2. Gastroenterology
8.3. Respiratory Infections Market
8.4. Skin Infection Treatment
8.5. Wound Prophylaxis
8.6. Urogenital Infection Treatment
8.7. Others
9. GLOBAL Bacteriophage MARKET, by Distribution Channel
9.1. Overview
9.2. Retail Pharmacies
9.3. Hospital Pharmacies
9.4. Online Pharmacies
10. GLOBAL Bacteriophage MARKET, by Region
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. Competitive Landscape
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Bacteriophage Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Bacteriophage Market,
11.7. Key developments and Growth Strategies
11.7.1. New Route of Administration Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. Company ProfileS
12.1. Life extension
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Route of Administrations Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Arthur Andrew Medical
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Route of Administrations Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Deerland Probiotics & Enzymes Inc.
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Route of Administrations Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. BIOCHIMPHARM
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Route of Administrations Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Micreos Human Health
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Route of Administrations Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Designs for Health
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Route of Administrations Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Accelerated Health Systems LLC
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Route of Administrations Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. The biostation
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Route of Administrations Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. MICROGEN
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Route of Administrations Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. IntraLytix Inc.
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Route of Administrations Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. Appendix
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 Global Bacteriophage Market, Synopsis, 2018-2032
TABLE 2 Global Bacteriophage Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 11 US Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 12 US Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 13 US Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 14 US Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 15 CANADA Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 16 CANADA Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 17 CANADA Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 18 CANADA Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 19 EUROPE Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 20 EUROPE Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 21 EUROPE Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 22 EUROPE Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 23 GERMANY Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 24 GERMANY Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 25 GERMANY Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 26 GERMANY Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 27 FRANCE Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 28 FRANCE Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 29 FRANCE Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 30 FRANCE Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 31 ITALY Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 32 ITALY Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 33 ITALY Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 34 ITALY Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 35 SPAIN Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 36 SPAIN Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 37 SPAIN Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 38 SPAIN Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 39 UK Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 40 UK Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 41 UK Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 42 UK Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 43 REST OF EUROPE Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 44 REST OF EUROPE Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 45 REST OF EUROPE Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 46 REST OF EUROPE Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 47 ASIA PACIFIC Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 48 ASIA PACIFIC Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 49 ASIA PACIFIC Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 50 ASIA PACIFIC Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 51 JAPAN Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 52 JAPAN Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 53 JAPAN Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 54 JAPAN Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 55 CHINA Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 56 CHINA Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 57 CHINA Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 58 CHINA Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 59 INDIA Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 60 INDIA Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 61 INDIA Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 62 INDIA Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 63 AUSTRALIA Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 64 AUSTRALIA Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 65 AUSTRALIA Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 66 AUSTRALIA Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 67 SOUTH KOREA Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 68 SOUTH KOREA Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 69 SOUTH KOREA Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 70 SOUTH KOREA Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 71 REST OF ASIA PACIFIC Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 72 REST OF ASIA PACIFIC Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 73 REST OF ASIA PACIFIC Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 74 REST OF ASIA PACIFIC Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 1 REST OF WORLD Bacteriophage MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 2 REST OF WORLD Bacteriophage MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 3 REST OF WORLD Bacteriophage MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 4 REST OF WORLD Bacteriophage MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 5 MIDDLE EAST Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 6 MIDDLE EAST Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 7 MIDDLE EAST Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 8 MIDDLE EAST Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 9 AFRICA Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 10 AFRICA Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 11 AFRICA Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 12 AFRICA Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
TABLE 13 LATIN AMERICA Bacteriophage MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 14 LATIN AMERICA Bacteriophage MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 15 LATIN AMERICA Bacteriophage MARKET, BY Application, 2018-2032 (USD BILLION)
TABLE 16 LATIN AMERICA Bacteriophage MARKET, by Distribution Channel, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Bacteriophage Market
FIGURE 3 Market Dynamics for the Global Bacteriophage Market
FIGURE 4 Global Bacteriophage Market, Share (%), BY Product Type, 2022
FIGURE 5 Global Bacteriophage Market, Share (%), BY Route of Administration, 2022
FIGURE 6 Global Bacteriophage Market, Share (%), BY Application, 2022
FIGURE 7 Global Bacteriophage Market, Share (%), BY Distribution Channel, 2022
FIGURE 8 Global Bacteriophage Market, Share (%), by Region, 2022
FIGURE 9 north AMERICA: Bacteriophage MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Europe: Bacteriophage MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Asia-Pacific: Bacteriophage MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 Rest of the world: Bacteriophage MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 Global Bacteriophage Market: Company Share Analysis, 2022 (%)
FIGURE 14 Life extension: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 Life extension: SWOT ANALYSIS
FIGURE 16 Arthur Andrew Medical: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 Arthur Andrew Medical: SWOT ANALYSIS
FIGURE 18 Deerland Probiotics & Enzymes Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 Deerland Probiotics & Enzymes Inc.: SWOT ANALYSIS
FIGURE 20 BIOCHIMPHARM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 BIOCHIMPHARM: SWOT ANALYSIS
FIGURE 22 Micreos Human Health.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 Micreos Human Health.: SWOT ANALYSIS
FIGURE 24 Citrix Systems, Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 Citrix Systems, Inc.: SWOT ANALYSIS
FIGURE 26 DESIGNS FOR HEALTH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 DESIGNS FOR HEALTH: SWOT ANALYSIS
FIGURE 28 Accelerated Health Systems LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 Accelerated Health Systems LLC: SWOT ANALYSIS
FIGURE 30 The biostation: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 The biostation: SWOT ANALYSIS
FIGURE 32 MICROGEN: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 MICROGEN: SWOT ANALYSIS
FIGURE 34 IntraLytix Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 IntraLytix Inc.: SWOT ANALYSIS